InvestSMART

Cordis Global Medical Technology - Managed Fund

Fund Objective
Cordis seeks capital growth over the long-term and significant outperformance over the S&P Global 1200 Healthcare Index
Fund Strategy
The Fund follows a fundamental long-only active strategy. Cordis runs a high conviction actively managed specialised portfolio, limited to between 20-40 stocks selected from the medical technology sub-sector of listed global healthcare companies.

Fund Performance Comparison

Relative Fund Performance vs {{ fund.benchmark.peers.peerCount }} peers using {{ fund.benchmark.name }} as their benchmark.

{{ fund.name }}
Peers
Benchmark ({{ fund.benchmark.name }})
{{ fund.model.name }}
The performance of the peers is calculated as the total of the performance for each time period for all the funds in the peer group, divided by the number of funds in the peer group.
Upsell Banner

Fund performance

  1M 3M 6M 1Y p.a. 2Y p.a. 3Y p.a. 5Y p.a. 10Y p.a.
Total return -0.56% -11.53% -15.54% -14.23% 11.48% -0.86% -% -%
Growth return -0.56% -11.53% -15.54% -14.23% 11.48% -0.86% -% -%
Income return 0% 0% 0% 0% 0% 0% -% -%
Market index (MSCI World Ex Australia NR AUD)
Total return 3.32% 6.34% 18.35% 22.32% 25.76% 20.9% 17.3% 12.82%
As at 31 Oct 2025. Returns for periods greater than 1 year are annualised. All figures are percentages.

General Information

Fund Details
Type Description
Cordis Global Medical Technology
Equity Trustees Ltd
ETL4642AU
Equity World Other
Not Rated
Investment Fund
30 Jun 2021
$12.9 million (as at 28 Feb 2023)
$1.0196 (as at 19 Nov 2025)
$1.0146 (as at 19 Nov 2025)
Open
Offer information
Type Description
MER 1.20% (as at 12 Mar 2024)
Minimum initial investment $50,000
Minimum additional investments $25,000,000
Your guide to next steps

Dealing with a struggling fund? What to Do and Look For

How to Assess your Managed Fund: And How to Choose the Next One
How to Assess your Managed Fund: And How to Choose the Next One
Your managed fund switching checklist. Is fear of capital gains tax holding you back?
Your managed fund switching checklist. Is fear of capital gains tax holding you back?
The Great Investment Fee Scam is hiding in plain sight. And it's ripping us all off.
The Great Investment Fee Scam is hiding in plain sight. And it's ripping us all off.
Guide to tidying up your Portfolio Manager holdings
Guide to tidying up your Portfolio Manager holdings

FAQs about the Cordis Global Medical Technology

The objective of the Cordis Global Medical Technology managed fund is Cordis seeks capital growth over the long-term and significant outperformance over the S&P Global 1200 Healthcare Index

The strategy of the Cordis Global Medical Technology managed fund is The Fund follows a fundamental long-only active strategy. Cordis runs a high conviction actively managed specialised portfolio, limited to between 20-40 stocks selected from the medical technology sub-sector of listed global healthcare companies.

The APIR code of the Cordis Global Medical Technology managed fund is ETL4642AU.

Cordis Global Medical Technology’s total return last month was -0.56%. This was made up of a growth return of -0.56% and an income return of 0%. These returns were calculated as at 31 Oct 2025.

Cordis Global Medical Technology’s total return for the last three months was -11.53%. This was made up of a growth return of -11.53% and an income return of 0%%. These returns were calculated as at 31 Oct 2025.

Cordis Global Medical Technology’s one-year total return is -14.23%. This was made up of a growth return of -14.23% and an income return of 0%. These returns were calculated as at 31 Oct 2025.

Cordis Global Medical Technology’s one-year total return is -0.86%. This was made up of a growth return of -0.86% and an income return of 0%. These returns were calculated as at 31 Oct 2025.

The asset allocation of the Cordis Global Medical Technology managed fund is :

International Equities
97.50%
Cash
2.50%
Australian Equities
0%
Property & Infrastructure
0%
Fixed Interest
0%
Alternatives
0%

The Responsible Entity for the Cordis Global Medical Technology managed fund is Equity Trustees Ltd.

The Cordis Global Medical Technology managed fund belongs to the Equity World Other sector/asset class.

As at 28 Feb 2023, the size of the Cordis Global Medical Technology managed fund was $12.9 million.

The Cordis Global Medical Technology managed fund has an inception date of 30 Jun 2021.

The current entry price of the Cordis Global Medical Technology managed fund is $1.0196 per unit and the current exit price is $1.0146 per unit (as at 19 Nov 2025).

The current exit price of the Cordis Global Medical Technology managed fund is $1.0146 per unit and the current entry price is $1.0196 per unit (as at 19 Nov 2025).

The minimum initial investment amount for the Cordis Global Medical Technology managed fund is $50,000. Minimum additional investment is $25000000.

Fund data sourced from Morningstar. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only. Whilst every care has been taken in producing these numbers, neither Morningstar nor InvestSMART can make any guarantees around the complete accuracy of these figures. Should you decide to change investments, please read all relevant disclosure documents including the Product Disclosure Statements and if required, you may consider speaking to a financial professional for further guidance. A tax event may be realised as a result of switching investments. Past performance is not a reliable indicator of future performance.